17 Sep 2018 Introducing the NeuClone Biosimilar Brief
Posted at 04:46h
in Biosimilars
The NeuClone Biosimilar Brief is a biosimilar industry publication written by NeuClone exploring biosimilar related matters we believe to be relevant to the industry.
What is the NeuClone Biosimilar Brief?
Objective: Providing simple but pertinent updates on the biosimilar landscape to broaden awareness and understanding of biosimilar medicines across various stakeholders.
Why: We are determined to increase affordability and patient access to life saving and life extending therapies. We hope the articles lead to increasing engagement and education on issues affecting biosimilars and their adoption across the world.
Contact: info@neuclone.com